SAMD9L and myasthenia gravis: Similarly, in the MG dataset (GSE85452), as depicted in Fig. 6F, the expression levels of C3AR1, IFIT2, IFI44L, SAMD9L, and MID1IP1 in MG patients were significantly lower compared to the control group (P < 0.05).